While the pandemic years were trying, at best, they gave us time to recognize, reevaluate and, in some instances, readjust the undesirable patterns we...
Healio: Alpha-Gal Screening In Asymptomatic Patients Not Cost-Effective
Cost and quality-adjusted life years of alpha-gal IgE screening vs. not screening in asymptomatic patients suggest that screening is not cost-effective.